China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Time-interference stimulation targeting cerebellar nuclei improves tremor disorders in ... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Clinical S... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Early Predictive Value of Serum MFG-E8 Levels for Sepsis-Associated Acute Kidney Injury... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical research on the efficacy and safety of digital therapy based on augmented real... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Association Between Preoperative Cognitive Reserve and Postoperative Delirium in Older ... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Concurrent Left Atrial Appendage Closure on Postoperative Arterial Thromboemb... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Seladelpar in Chinese Patients with Primary Biliary Cholangitis:... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive Stage Small Cell Lung Cancer After ... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of ATR measurements among different curvetypes and analysis of Cobbangle scr... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparative Analysis of the Efficacy and Safety of Nafamostat Mesylate and Unfractionat... Read More